Organ procurement and transplantation during the COVID-19 pandemic

End-stage organ failure is estimated to affect more than six million people worldwide.1 In 2018, transplant systems across the world enabled around 150 000 patients to benefit from a kidney, heart, lung, liver, or other solid organ—a number far less than the demand. According to data from WHO, more...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet 2020-05, Vol.395 (10237), p.e95-e96
Main Authors: Loupy, Alexandre, Aubert, Olivier, Reese, Peter P, Bastien, Olivier, Bayer, Florian, Jacquelinet, Christian
Format: Article
Language:English
Subjects:
Betacoronavirus
Blood & organ donations
Coronavirus Infections
Coronaviruses
COVID-19
Emerging diseases
Health care
Human health and pathology
Humans
Life Sciences
Microbiology and Parasitology
Pandemics
Pneumonia, Viral
Public health
SARS-CoV-2
Surgery
Tissue and Organ Procurement
Transplantation
Transplants & implants
Virology
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:End-stage organ failure is estimated to affect more than six million people worldwide.1 In 2018, transplant systems across the world enabled around 150 000 patients to benefit from a kidney, heart, lung, liver, or other solid organ—a number far less than the demand. According to data from WHO, more than 1 500 000 people live with a transplanted organ worldwide. Because of the overwhelming health-care system burden of the COVID-19 pandemic, a pronounced negative effect on worldwide organ donation and transplantation is anticipated but has not been measured.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(20)31040-0